Le Lézard
Classified in: Health, Business
Subject: ATY

NEVRO HOLDINGS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nevro Corp. - NVRO


NEW ORLEANS, Sept. 21, 2018 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against Nevro Corp. (NYSE: NVRO), if they purchased the Company's shares between January 8, 2018 and July 12, 2018, inclusive (the "Class Period").  This action is pending in the United States District Court for the Northern District of California.

Get Help

Nevro investors should visit us at https://www.claimsfiler.com/cases/view-nevro-corporation-securities-litigation or call toll-free (844) 367-9658.  Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.  

About the Lawsuit

Nevro and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On July 10, 2018, analysts reported that a tentative court ruling in patent litigation involving Nevro nullified at least five patents related to the Company's "proprietary" HF10 pain therapy and Senza delivery systems, which resulted in some analysts downgrading the Company.  Then, on July 13, 2018, the Company disclosed pre-market that it had terminated the employment of James Alecxih, Vice President, Worldwide Sales.

News of both events caused the price of Nevro's shares to plummet, wiping out over $650 million in market capitalization.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

 

SOURCE ClaimsFiler


These press releases may also interest you

at 11:15
Variantyx, a leader in molecular diagnostics, announced today that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures....

at 11:03
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

at 11:00
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023,...

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...



News published on and distributed by: